Virnetx Engaging IPValue Regarding Patent Licensing

VirnetX™ Holding Corporation (NYSE MKT:

), an Internet security software and technology company, announced today that it has engaged IPVALUE Management Inc. to assist it in commercializing its portfolio of patents on securing real-time communications over the Internet. Under the multi-year agreement, IPVALUE will originate and assist VirnetX with negotiating transactions related to patent licensing worldwide with respect to agreed third parties. "The technology innovations giving rise to the VirnetX patent portfolio have tremendous value as secure communications are the fundamental building blocks of today's mobile, internet connected devices and services." said Murali Dharan, IPVALUE CEO. "VirnetX's strong intellectual property portfolio includes patents that have been declared essential to 3GPP mobile standards and we look forward to opening discussions with companies that need this technology to be compliant. IPVALUE has a proven track record of applying a professional, business resolution oriented approach to licensing marquee intellectual properties like VirnetX's IP." "We're excited about our relationship with IPVALUE," said Kendall Larsen, VirnetX CEO and President. "We believe that working with the IPVALUE team will provide us with the resources to fully commercialize our patent portfolio and maximize the revenue potential of our intellectual property." VirnetX's worldwide portfolio includes over 107 U.S. and foreign patents with over 75 pending applications. Its portfolio has been licensed by a number of leading technology companies including a recent licensing agreement with Microsoft. VirnetX has submitted a declaration with the 3rd Generation Partnership Project (3GPP) identifying a group of its patents and patent applications that it believes are essential to 19 specifications in the 3GPP LTE, SAE project. VirnetX patent development is attributed to the VirnetX research and development team, headed by VirnetX Chief Technical Officer and Chief Scientist, Dr. Robert Dunham Short III, which includes the scientists who created the original inventions that are the basis of VirnetX's patent portfolio. The VirnetX R & D team continues to file for new patents on any improvements or new technology it invents while developing VirnetX products including Gabriel Secure Communications (scheduled for public release the first half of 2015) and VirnetX's Secure Domain Name Registry.